American Association for Cancer Research Inc
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$291,810,436
Cash & Equivalents
47%
Investments
36%
Receivables (Non-Related)
9%
Other Assets
7%
Prepaid Expenses
1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$71,615,546
Deferred Revenue
32%
Other Liabilities
30%
Grants Payable
21%
Payables & Accruals
16%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$23,193,839
$135,725,004
+485%
Receivables (Non-Related)
$24,966,889
$25,655,532
+3%
Related-Party Receivables
-
$0
-
Inventories
-
$0
-
Prepaid Expenses
$4,512,664
$3,164,476
-30%
Investments
$177,775,046
$105,834,699
-40%
Property, Plant, & Equipment (net)
$154,051
$65,266
-58%
Other Assets
$11,347,096
$21,365,459
+88%
Total Assets
$241,949,585
$291,810,436
+21%
Liabilities
2023
2024
Change
Payables & Accruals
$10,140,532
$11,636,511
+15%
Grants Payable
$20,502,827
$15,033,325
-27%
Deferred Revenue
$28,940,684
$23,272,063
-20%
Tax-Exempt Bond Liabilities
-
$0
-
Custodial & Escrow Liabilities
-
$0
-
Notes Payable / Debt (Non-Related)
-
$0
-
Related-Party Payables
-
$0
-
Other Liabilities
$11,901,189
$21,673,647
+82%
Total Liabilities
$71,485,232
$71,615,546
+0%
Net assets
2023
2024
Change
Restricted Net Assets
$14,397,163
$12,236,389
-15%
Unrestricted Net Assets
$156,067,190
$207,958,501
+33%
Net assets
2023
2024
Change
Net assets
+$170,464,353
+$220,194,890
+29%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)